Oxygenta Pharmaceutical Limited (BOM:524636)
India · Delayed Price · Currency is INR 67.43
+2.05 (3.14%)
At close: Aug 17, 2026
Oxygenta Pharmaceutical Market Cap
Oxygenta Pharmaceutical has a market cap or net worth of 2.49 billion as of August 17, 2026. Its market cap has decreased by -24.07% in one year.
Market Cap
2.49B
Enterprise Value
3.57B
Revenue
1.35B
Ranking
n/a
PE Ratio
n/a
Stock Price
67.43
ChartMarket Cap Chart
Since June 4, 1997, Oxygenta Pharmaceutical's market cap has increased from 7.22M to 2.49B, an increase of 34,455.97%. That is a compound annual growth rate of 22.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 2.49B | 20.86% |
| Dec 31, 2025 | 2.06B | -36.22% |
| Dec 31, 2024 | 3.23B | 210.06% |
| Dec 29, 2023 | 1.04B | 159.15% |
| Dec 30, 2022 | 402.61M | 2.53% |
| Dec 31, 2021 | 392.67M | 307.32% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BDH Industries | 3.14B |
| Medicamen Biotech | 3.06B |
| Astonea Labs | 2.92B |
| Everest Organics | 2.81B |
| Gennex Laboratories | 2.63B |
| Sanjivani Paranteral | 2.40B |
| Accretion Pharmaceuticals | 2.12B |
| Coral Laboratories | 2.05B |